Ftse Mib
34.492,41
0,13%
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
NASDAQ
16.735,02
-0,01%
Bitcoin
67.706,06
0,33%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. USOTC Pathfinder Cell Therapy Inc (CE) (PFND) Pathfinder Cell Therapy Inc (CE) (PFND) Notizie

PFND

Pathfinder Cell Therapy (CE) (PFND)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:PFND
DataOraFonteTitoloSimboloCompagnia
05/04/201612:01Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
30/03/201622:16Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
29/03/201623:26Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
29/03/201621:26Edgar (US Regulatory)Current Report Filing (8-k)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
29/03/201619:40Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
13/11/201517:23Edgar (US Regulatory)Quarterly Report (10-q)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
31/03/201518:19Edgar (US Regulatory)Annual Report (10-k)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
27/05/201422:25Edgar (US Regulatory)Amended Annual Report (10-k/a)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
29/04/201419:39Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
31/03/201421:52Edgar (US Regulatory)Quarterly Schedule of Portfolio Holdings of Registered Management Investment Company (n-q)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
14/08/201321:13Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
06/03/201323:33Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
15/01/201314:28Edgar (US Regulatory)Current report filing (8-K)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
28/12/201217:01Edgar (US Regulatory)Semi-annual Report (management Company) (nsar-a)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
07/12/201219:04Edgar (US Regulatory)Certified Annual Shareholder Report for Management Investment Companies (n-csr)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
15/05/201216:26Edgar (US Regulatory)Quarterly Report (10-Q)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
30/04/201220:06Edgar (US Regulatory)Amended Annual Report (10-K/A)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
30/03/201218:40Edgar (US Regulatory)Annual Report (10-K)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
21/02/201214:01GlobeNewswire Inc.Pathfinder Presents Preliminary Data on New Regenerative Approach to Diabetes TreatmentUSOTC:PFNDPathfinder Cell Therapy Inc (CE)
16/02/201214:00GlobeNewswire Inc.Pathfinder to Present at New York Stem Cell SummitUSOTC:PFNDPathfinder Cell Therapy Inc (CE)
15/02/201214:00GlobeNewswire Inc.Pathfinder Announces First European Patent Allowance for Pathfinder CellsUSOTC:PFNDPathfinder Cell Therapy Inc (CE)
06/01/201200:13Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
16/12/201122:34Edgar (US Regulatory)Statement of Beneficial Ownership (SC 13D)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
16/12/201100:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
13/12/201116:00GlobeNewswire Inc.Pathfinder Cell Therapy Provides Update on Pathfinder Cell Research and DevelopmentUSOTC:PFNDPathfinder Cell Therapy Inc (CE)
15/11/201123:13Edgar (US Regulatory)Notification that Quarterly Report will be submitted late (NT 10-Q)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
03/10/201122:44Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:PFNDPathfinder Cell Therapy Inc (CE)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:PFND

La tua Cronologia

NASDAQ
FMCLBX
Global Commodities Oppor...
NASDAQ
ACHL
Achilles Therapeutics
NASDAQ
TIGO
Millicom International C...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network